US Broker Ratings

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside

In the rapidly evolving healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves with its innovative approach to treating obstructive sleep apnea (OSA). The..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook Reveals 56% Potential Upside Amid Robust Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its compelling potential upside of 56.48%, driven by its innovative approach in the biotechnology sector. As..

Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 49.49% Potential Upside in the Medical Devices Sector

Investors seeking opportunities within the healthcare sector should take a closer look at Glaukos Corporation (NYSE: GKOS), a notable player in the medical devices industry. With..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Riding the Wave of a 57% Potential Upside

For investors with an eye on the healthcare sector, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents a compelling opportunity. Specializing in digital healthcare, iRhythm is at the..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 38% Upside Potential Despite Recent Challenges

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, has been a staple in the plasma-derived medicines market for over a century. Headquartered..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Promising 112% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) presents a compelling opportunity for investors with its innovative approach in the biotechnology sector. Specializing in vaccine development, this clinical-stage company is..

BioMarin Pharmaceutical Inc. (BMRN): Analyst Consensus Suggests a 53% Upside for a Biotech Innovator

BioMarin Pharmaceutical Inc. (BMRN), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline and strategic focus on therapies for..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a High-Growth Biotech with 15% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its innovative approach to central nervous system (CNS) disorders. With a market capitalization..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: High Buy Ratings and Promising Growth Prospects

For investors keeping an eye on the healthcare sector, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents a compelling case with its strong market positioning in the specialty..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.96% Upside Potential

Biogen Inc. (BIIB), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, presents a compelling case for investors with its robust portfolio..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 21% Potential Upside Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: Evaluating the Healthcare Tech Innovator’s Growth Trajectory

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology landscape, has been attracting significant attention from investors, thanks to its impressive revenue growth..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 8% Potential Upside Amidst Mixed Performance Metrics

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, presents a mixed bag of metrics that..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 31.90% Revenue Growth and Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a dynamic player within the biotechnology sector, carving its niche with groundbreaking genetic medicines aimed at treating diseases with significant..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 12.47% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a heavyweight in the diagnostics and research industry with a market capitalization of $23.86 billion, is a company that continues to..

Bruker Corporation (BRKR) Stock Analysis: Navigating a Challenging Valuation with Promising Growth in Medical Devices

Bruker Corporation (NASDAQ: BRKR) is a prominent name in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.96 billion, Bruker..

Cencora, Inc. (COR) Stock Analysis: Evaluating a 32% Upside Potential in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, particularly in medical distribution, has piqued investor interest with its recent name change from AmerisourceBergen..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 13.89% Potential Upside

For investors eyeing the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents intriguing opportunities. With a market capitalization of $8.72 billion, this U.S.-based medical distribution giant..

The Cigna Group (CI) Stock Analysis: Exploring a Solid 23.11% Potential Upside

As the healthcare sector continues to attract investor interest, The Cigna Group (NYSE: CI) emerges as a compelling option with promising growth potential. With a robust..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 30% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the Health Information Services industry, is catching the eye of investors with its significant potential upside. Trading at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds